Inventor · disambiguated record
Pradip Nair
Also filed as: NAIR PRADIP
11 granted patents·9 pending applications·50 citations·filing 2008–2024
89Inventor score
Top patents by PatentIndex Score
20 records- 0190US9670285B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2015·Granted Jun 6, 2017·7 cites·4 claims
- 0289US10669346B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2018·Granted Jun 2, 2020·2 cites·12 claims
- 0389US10000573B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2017·Granted Jun 19, 2018·6 cites·9 claims
- 0489US8524233B2Monoclonal antibody and a method thereofMELARKODE RAMAKRISHNAN·Filed 2008·Granted Sep 3, 2013·14 cites·6 claims
- 0588US9217037B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2013·Granted Dec 22, 2015·8 cites·2 claims
- 0687US2024417483A1Monoclonal antibody and a method thereofBIOCON LTD·Filed 2024·Application pending·0 cites
- 0786US11028168B2Use of a CD6 binding partner and method based thereonBIOCON LTD·Filed 2018·Granted Jun 8, 2021·3 cites·8 claims
- 0885US11981743B2Monoclonal antibody and a method thereofBIOCON LTD·Filed 2020·Granted May 14, 2024·1 cites·11 claims
- 0979US9856502B2Methods for controlling fucosylation levels in proteinsBIOCON LTD·Filed 2014·Granted Jan 2, 2018·6 cites·5 claims
- 1073US10189899B2Use of a CD6 binding partner and method based thereonBIOCON LTD·Filed 2014·Granted Jan 29, 2019·2 cites·6 claims
- 1171US2024343813A1Combination therapy and related methodsBICARA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1269US11242401B2Monoclonal antibody and a method of use for the treatment of lupusBIOCON LTD·Filed 2017·Granted Feb 8, 2022·1 cites·7 claims
- 1368US2024101700A1Use of itolizumab to reduce phosphorylation of cd6BIOCON LTD·Filed 2023·Application pending·0 cites
- 1465US2022025038A1Use of a cd6 binding partner and method based thereonBIOCON LTD·Filed 2021·Application pending·0 cites
- 1560US2022227880A1Monoclonal antibody and a method of use for the treatment of lupusBIOCON LTD·Filed 2021·Application pending·0 cites
- 1658US2024082394A1Combination therapy for the treatment of cancerBICARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1753US2024392031A1Caix targeting il-12 fusion proteins and methods of use thereofBICARA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1852US2019248913A1Use of itolizumab to reduce phosphorylation of cd6BIOCON LTD·Filed 2019·Application pending·0 cites
- 1951US10308970B2Methods for controlling fucosylation levels in proteinsBIOCON LTD·Filed 2017·Granted Jun 4, 2019·0 cites·5 claims
- 2049US2023151107A1Anti-cd6 antibody compositions and methods for treating and reducing negative effects of a coronavirus including covid-19BIOCON LTD·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →